INTS logo

Intensity Therapeutics, Inc. Common stock


INTS: Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors.


Show INTS Financials

Consumer Interest
SEC Filings

Recent trades of INTS by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard

Quarterly net insider trading by INTS's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Method of treating cancer Jan. 12, 2021
  • Patent Title: Method of treating cancer May. 02, 2017
  • Patent Title: Method of treating cancer May. 31, 2016
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of INTS in WallStreetBets Daily Discussion


Recent insights relating to INTS

CNBC Recommendations

Recent picks made for INTS stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in INTS

Corporate Flights

Flights by private jets registered to INTS